For healthcare professionals only


In brief

BMJ 2005; 331 doi: (Published 07 July 2005) Cite this as: BMJ 2005;331:66

Colon cancer drugs to be more widely available: The UK National Institute for Health and Clinical Excellence (NICE) has decided that two chemotherapy drugs for advanced bowel cancer, irinotecan and oxaliplatin, should be more widely available to patients. It follows a concerted campaign by Colon Cancer Concern, clinicians, patients, and other groups that have urged NICE to increase access to these …

View Full Text

Log in

Log in through your institution


* For online subscription